PHAT ▼ -0.1% - Phathom Pharmaceuticals, Inc.
$PHAT - Phathom Pharmaceuticals Highlights New Cost-Effectiveness Data and Growing Clinical Interest in VOQUEZNA® (vonoprazan) at ACG 2026
12-OCT-2026 08:00 AM ET
Share this post
More filings for $PHAT
PHAT - Phathom Pharmaceuticals, Inc. - SEC Filing Update (10-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 10, 2026PHAT ▼ -0.5% - Phathom Pharmaceuticals, Inc.Nov 4, 2026PHAT - Phathom Pharmaceuticals, Inc. - SEC Filing Update (02-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 2, 2026PHAT ▲ +6.4% - Phathom Pharmaceuticals, Inc.Oct 29, 2026PHAT ▼ -2.1% - Phathom Pharmaceuticals, Inc.Oct 23, 2026PHAT ▲ +1.6% - Phathom Pharmaceuticals, Inc.Oct 19, 2026
View full $PHAT filing history →💬 Comments
Loading comments…
Leave a comment
